| 样本编号 | SAMC4253184 |
|---|---|
| 外部数据库编号 | GSA-Human: HRS1385019 |
| 样品名称 | 220028052 |
| 样本标题 | P220028052 |
| 样品类型 | Human sample |
| 物种名称 | Homo sapiens |
| 描述信息 | Post-NAC blood from patient NAC112 for 1021 panel |
| 样本属性 | *该样本包含更多受控访问信息,请通过GSA-Human系统申请项目HRA008824数据获取。 |
| 发布日期 | 2025-02-22 |
| 项目编号 | PRJCA030340 |
| 提交者 | Qin Li (liuq77@mail.sysu.edu.cn) |
| 提交单位 | Geneplus-institute, Beijing |
| 提交日期 | 2024-10-15 |
| 资源名称 | 描述 |
|---|---|
| GSA-Human (1) | - |
| HRA008824 (Controlled Access) | Neoadjuvant chemotherapy(NAC) is traditionally for locally advanced disease, converting an inoperable to a resectable tumor. In recent years, it has become an option for patients of lower tumor stage to increase the possibility of breast-conserving therapy. An effective method to monitor the response to NAC is important. Investigators aim to investigate whether circulating tumor DNA is a sensitive marker to evaluate patients' response to neoadjuvant chemotherapy. |